U.S.-China Relations
NextFin News - China's chemical exporters are running flat out, and the rest of the world is reaching for its trade-remedy rulebook. Chinese chemical shipments reached RMB 1.60 trillion in the first half of 2026, with industry profits jumping 65.2% year on year, as a wall of new petrochemical capacity built for self-sufficiency collides with soft domestic demand. The overflow is heading for Europe and emerging markets — and Washington and Brussels are answering with antidumping cases, countervailing duties, and tariff probes that risk turning chemicals into the next front of the global trade war.
The numbers are stark enough to explain the alarm. China's exports of organic chemicals alone reached US$84.25 billion in 2025, and chemical products as a whole became the country's sixth-largest export category at US$205 billion. Polyethylene shipments, a bellwether for commodity plastics, rose 258.1% by volume in the first half of 2026. Behind the surge sits a simple imbalance: capacity added for a domestic consumer boom that never materialized is now hunting for buyers abroad, and the buyers are starting to push back.
This is not a routine cyclical uptick in exports. It is the visible symptom of a structural shift in the global chemical industry — one that trade barriers can delay but will not reverse. The question for investors and policymakers is not whether the surge will stop, but how far governments are willing to go to contain it, and who ends up paying for the overcapacity that China's industrial policy created.
The Overcapacity Machine: Why the Surge Will Not Self-Correct
China's chemical export surge is a supply-side phenomenon first and a demand-side phenomenon second. During the 2021-2025 investment wave, Chinese refiners and petrochemical producers built capacity on the assumption that domestic consumption would keep rising at double-digit rates. Instead, the property slump that began in 2021 hollowed out demand for plastics, synthetic fibers, and construction chemicals, while the electrification of the vehicle fleet eroded gasoline and diesel demand — leaving refineries to push more naphtha into chemical feedstocks rather than fuel. The result is a structural mismatch that no amount of price-cutting can fully absorb.
The capacity figures tell the story. China's purified terephthalic acid (PTA) capacity has doubled to 92 million metric tons since 2019, according to China Chemical Fibre. Bottle-grade PET chip capacity has doubled to 22 million metric tons over the past three years, Guotai Junan Futures said, and global PET nameplate capacity is projected to reach roughly 43 million tons with China accounting for about half. China added 4.2 million tons of PET capacity in 2024 and another 2.0 million tons in 2025. This is not capacity that can be idled quietly: integrated producers from textiles to refineries have cost structures that allow them to run at a loss longer than their competitors can survive.
And run at a loss they are. PTA units using advanced technology — more than 60% of total capacity in 2025 — were losing about 21 yuan per ton, while older units were losing around 561 yuan per ton, consultancy Oilchem estimated in October 2025. Negative margins across a majority of an industry's capacity would, in a normal market, trigger closures. In China's chemical sector, state-backed balance sheets and local-employment priorities have kept the units running, converting what would have been a domestic supply correction into an export wave.
"The U.S. tariffs also squeezed PTA profits from exports of downstream textiles and apparel," said Xiaoqin He, an analyst at Guotai Junan Futures, in comments carried by industry press in October 2025.
The cyclical counter-argument deserves a hearing. Global demand is improving gently through 2026, led by packaging, construction repair, and electronics, and some of the excess capacity is being absorbed. Commodity polymer prices have found a floor after falling to five-year lows, with most polymers down roughly US$1,000 per ton from their 2021-2022 peaks. If the global economy avoids a hard landing, the argument goes, the surplus will work off naturally within two to three years.
That view mistakes a price floor for a supply fix. Prices have stabilized because producers are absorbing losses, not because supply and demand have come into balance. A cyclical recovery requires mean reversion — capacity exiting, margins normalizing, inventories drawing down. None of that has happened at scale. Until announced closures exceed announced additions for a full year, the overcapacity is a permanent feature of the market, not a passing wave. This is a structural regime shift: the adjustment mechanism has moved from the market to the customs house.
The Trade-Remedy Counterattack: Chemicals Join the Managed-Trade Bloc
Governments are responding with the full arsenal of trade defense, and the pace of filings has accelerated sharply in 2026. The United States and the European Union have moved from generic tariff threats to product-specific antidumping and countervailing-duty actions that target the exact molecules where China's export surge is concentrated.
On April 8, 2026, the U.S. Department of Commerce announced final affirmative antidumping determinations on methylene diphenyl diisocyanate (MDI) from China, a key feedstock for foams used in construction and appliances. The department set dumping margins of 85.11% for Covestro Polymers (China) and Shandong Mingko/Wanhua Chemical Group, and a China-wide entity rate of 159.04% based on adverse facts available. The petitioners were BASF Corporation and The Dow Chemical Company, operating through the Ad Hoc MDI Fair Trade Coalition — a sign that the pressure is coming from producers, not just politicians. Commerce noted that U.S. imports of MDI from China had risen from 163.9 million kilograms in 2022 to 198.8 million kilograms in 2024, even as import values fell from US$345.6 million to US$241.0 million — the textbook signature of dumping, volume up while unit values collapse.
The MDI case is one of several closing in 2026. The U.S. International Trade Commission issued an affirmative final injury determination on Chinese L-lysine on August 18, 2026, after the Commerce Department completed its antidumping and countervailing-duty final determinations in July, paving the way for duties on the animal-feed additive. The European Commission initiated an antidumping investigation into acrylic esters from the United States, China, Saudi Arabia, and South Africa on March 12, 2026, with a preliminary determination due November 12, 2026 and a final determination by May 11, 2027. The EU also opened an antidumping proceeding on adipic acid from China in March 2025, launched an expiry review of citric acid duties in April 2026 followed by an interim review in September 2026, and imposed provisional antidumping duties on Chinese sodium benzoate in 2026.
Beyond product-specific cases, the tariff backdrop has hardened. A separate 12.5% forced-labor duty has applied to most Chinese goods since July 24, 2026, layered on top of Section 301 tariffs of 25% on Lists 1 through 3. Medical and surgical rubber gloves face a 100% tariff from January 1, 2026, and lithium-ion non-electrical-vehicle batteries, permanent magnets, and natural graphite all moved to 25% on the same date.
Beijing is not absorbing these blows passively. On October 2, 2026, China's Ministry of Commerce launched an antidumping investigation into p-nitrotoluene from the European Union after domestic producers complained of damage to production and operations — a calibrated retaliation that targets EU chemical exporters rather than American ones. China has also imposed dairy levies of up to 42.7% in earlier rounds of the dispute. The tit-for-tat is escalating from steel and electric vehicles into the chemical value chain, where both sides have concentrated exposure.
Second-Order Effects: Diversion, Price Suppression, and the Data That Does Not Add Up
The first-order effect of trade barriers is obvious: duties raise the landed cost of Chinese chemicals in the imposing market. The second-order effects are more consequential and less widely priced in. When the U.S. and EU close their doors, Chinese volumes do not disappear — they divert. Europe's trade deficit with China widened to a record €359.8 billion in 2025, up 18% year on year, as imports from China rose 6.4% to €559.4 billion while EU exports to China fell 6.5% to €199.6 billion, according to Eurostat. Chinese exports to the EU jumped 14% in September 2025, the largest monthly rise in more than three years, as goods once bound for the United States were redirected across the Atlantic.
But the diversion story has a darker twist: a significant share of the redirected volume may be transshipped through third countries rather than genuinely re-sourced. Research from the Peterson Institute for International Economics found a widening gap between what China reports exporting to the United States and what the United States reports importing from China. From January through July 2026, the U.S. Census Bureau recorded US$158.3 billion in merchandise imports from China, while China reported US$258.1 billion in exports to the United States — a US$99.8 billion difference equivalent to 63% of reported U.S. imports, nearly five times the 2021-2024 average. By July 2026, China's reported monthly exports to the U.S. were only about 4% below their 2024 average, while U.S.-reported imports were 26% below. The gap is the footprint of tariff evasion through rerouting via Southeast Asia, Mexico, and other intermediaries — meaning the trade barriers are suppressing recorded bilateral trade without necessarily reducing the underlying flow of Chinese-made molecules into American supply chains.
The third-order effect is global price suppression. China's commodity polymer exports jumped 29% in volume through July 2025 to 11.1 million tons, with gains to every region except North America, while average prices sank to their lowest levels in more than five years. That is deflation exported: downstream users in packaging, construction, and consumer goods benefit from cheaper inputs, but producers outside China face margin compression that forces consolidation. The EU's chemical industry, which ran a €238 billion trade surplus in 2024 and counted China as its largest import source, is caught in the middle — defending its home market with duties while losing export share in China to retaliation.
Here the consensus read needs challenging. The conventional wisdom is that trade barriers protect domestic producers. In chemicals, they may instead entrench the very overcapacity they aim to cure. By walling off the U.S. and EU markets, tariffs confine Chinese volumes to a narrower set of destinations, intensifying competition and price-cutting in ASEAN, India, and Latin America. That accelerates margin collapse for non-Chinese producers in those markets — the ones least able to lobby for protection — while Chinese integrated producers, subsidized and scale-driven, survive on volume. The barriers change the geography of the surplus; they do not eliminate it.
Who Wins, Who Loses, and What to Watch
The beneficiaries and the exposed are asymmetric, and the asymmetry cuts across time horizons.
In the short term — the next six to twelve months — the winners are Chinese integrated producers with the balance sheets to run through losses, and the petitioners who secured the duties: BASF, Dow, and their EU and U.S. peers in MDI, lysine, and acrylates gain protected home-market share. The losers are chemical exporters to China, who are now explicit retaliation targets, and merchant producers without scale in Europe and the United States, who face cheap imports in every market except their own. Downstream users — packaging, automotive, construction — get a temporary input-cost reprieve that reverses the moment duties bite through the supply chain.
Over the medium term, one to three years, the key variable is whether the losses force capacity rationalization. If PTA and PET operators begin shutting units faster than new projects start up, global balances improve and the survivors — Chinese and non-Chinese alike — see margins recover. If, as has been the pattern since 2023, closures remain isolated and state-backed producers keep running, the surplus persists and trade barriers multiply into a managed-trade regime for chemicals resembling what already exists for steel and electric vehicles.
Over the long term, the structural outcome is a bifurcated chemical trade system: a protected bloc of U.S. and EU markets walled off from China, and a contested rest-of-world market where Chinese volumes compete on price against everyone else. That is a less efficient global industry, with higher costs in the protected bloc and lower margins everywhere else — inflationary for Western consumers of chemical-intensive goods, deflationary for commodity producers, and a persistent drag on the profitability of any chemical company without a protected home market or differentiated specialty products.
Three signals will tell investors which path the industry is taking. First, if China's chemical export growth slows to below 5% year on year in the second half of 2026, the structural-overcapacity thesis weakens and the surge was more cyclical than assessed here. Second, if announced capacity closures exceed announced additions for a full year, rationalization has begun and the margin trough is behind the sector. Third, if the U.S.-China import-export data gap narrows materially — if U.S.-reported imports from China stop running roughly 25% below China-reported exports — the transshipment channel is closing and the trade barriers are actually reducing flows rather than redirecting them.
The base case is escalation without explosion: chemicals join electric vehicles and steel as managed-trade sectors, with duties accumulating product by product but stopping short of a broad China-EU trade war. The upside case is that Chinese stimulus lifts domestic consumption enough to absorb surplus capacity, easing export pressure and de-escalating the dispute. The downside case is that retaliation spirals — p-nitrotoluene is only the opening move — and chemicals become the trigger for a wider China-EU confrontation that spills into machinery, luxury goods, and aerospace.
China built a chemical industry sized for a consumer boom that never arrived. Now the bill for that miscalculation is being presented not in Shanghai or Beijing, but in the trade-remedy dockets of Brussels and Washington — and the rest of the chemical world will be paying it for years.
Explore more exclusive insights at nextfin.ai.
